Abstract
-
Objective
To assess the prevalence of peripheral neuropathy in patients with rheumatoid arthritis (RA) having neuropathic symptoms, and to investigate the relationship between electrophysiological findings of peripheral neuropathy and clinical findings of RA.
-
Methods
Patients with a clinical diagnosis of RA and who had tingling or burning sensation in any extremity were electrophysiologically examined for evidence of peripheral neuropathy. Study parameters, including age, gender, laboratory parameters, duration of RA, and medication, were recorded. The symptoms and signs of neuropathy were quantified with the neuropathy symptom score, and the functional statuses of these patients were assessed.
-
Results
Out of a total of 30 RA patients, 10 (33%) had peripheral neuropathy: 2 had bilateral carpal tunnel syndrome (CTS), 5 had unilateral CTS, 1 had sensory polyneuropathy, and 2 had motor-sensory polyneuropathy. The mean ages of the patients with and without peripheral neuropathy were 69.4 and 56.5 years, respectively (p<0.05). A significant relationship was found between peripheral neuropathy and anti-cyclic citrullinated peptide (anti-CCP) antibody. However, no relationship was found between peripheral neuropathy and the type of medication, RA duration, the patients' functional status, neuropathic symptoms, erythrocyte sedimentation rate, and C-reactive protein values.
-
Conclusion
Neuropathic symptoms are common in RA patients, and it is difficult to distinguish peripheral neuropathy symptoms from those of arthritis. Patients with RA, particularly elderly patients and anti-CCP antibody positive patients who complain of neuropathic symptoms should undergo electrophysiological examination.
-
Keywords: Rheumatoid arthritis, Peripheral neuropathy, Anti-cyclic citrullinated peptide
INTRODUCTION
Rheumatoid arthritis (RA) is a systemic inflammatory disease that mainly affects the joints [
1]. Although the main manifestations involve the joints, previous studies have reported that extra-articular manifestations occur in 10%-20% of RA patients and that these symptoms correlate with increased mortality [
2]. Clinical neuropathy occurs in 0.5% to 85% of RA patients [
3,
4,
5,
6], and presents in the form of mononeuritis multiplex, sensorimotor neuropathy, and entrapment neuropathy [
5]. Clinical neuropathy may present with a wide variety of symptoms, such as pain, paresthesias, and muscle weakness. These symptoms may mimic and overlap those of arthritis, and it is difficult to distinguish peripheral neuropathy symptoms from arthritis symptoms.
The various causes of peripheral neuropathy in RA include nerve entrapment, drug toxicity, vasculitis, and rarely amyloidosis [
7,
8]. A few studies also suggest that the development of RA can be attributed to an autoimmune phenomenon [
9,
10]. However, few reports have explored the relationship between peripheral neuropathy and clinical findings in RA patients. The aim of this study was to electrophysiologically evaluate peripheral neuropathy in RA patients with neurologic symptoms, and to demonstrate the relationships between peripheral neuropathy and demographic, clinical, and laboratory findings.
MATERIALS AND METHODS
Patients
Patients with a clinical diagnosis of RA who had tingling or burning sensation in any extremity were enrolled in this study. All of the patients met the American College of Rheumatology criteria for RA [
11]. Exclusion criteria were 1) patients with systemic diseases or conditions that are associated with neuropathy (i.e., diabetes mellitus, hypothyroidism, amyloidosis, alcohol intake, liver failure, chronic renal failure treated by hemodialysis, or pregnancy), 2) patients who underwent orthopedic surgery, and 3) patients with neurologic disorders. The recorded parameters included age, gender, duration of RA, laboratory test results, medications, neuropathic symptoms, and functional status. Laboratory tests included erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), and anti-cyclic citrullinated peptide (anti-CCP) antibody.
Neuropathic symptom measurement
Neuropathic symptoms and signs were quantified with the neuropathy symptom scale (NSS). The NSS is a five-question multiple-choice self-report inventory that is used for measuring the severity of neuropathic symptoms and signs. The NSS has a maximum score of 9, with a higher score indicating more severe neuropathic symptoms [
12]. The functional status of patients with RA was classified as class I-IV according to the revised criteria for the classification of the functional status in RA. A higher class reflects a poorer functional status [
13].
Electrophysiological study
Electrophysiological studies were performed using the Medelec-Synergy EMG instrument (Oxford Instrument Co., Surrey, UK). The skin temperature was kept between 31℃ and 32℃. Median, ulnar, peroneal, and posterior tibial motor nerve conduction studies (NCSs), including F-waves, were performed unilaterally on the symptomatic side. Median, ulnar, superficial peroneal, and sural sensory NCSs were performed unilaterally on the symptomatic side. The latency of the H-wave was measured bilaterally. Motor NCSs were performed using the belly-tendon method. Sensory nerve conduction was studied antidromically. All amplitudes were determined based on the base-to-peak value; the peak latency and onset latency were measured for sensory nerve action potential (SNAP) and compound motor action potential (CMAP), respectively. The conduction velocity of each nerve was measured. Findings were compared with the reference values that are used in our center as described in
Table 1.
A bilateral study of three extremities was conducted if the NCS showed abnormal findings. Polyneuropathy was diagnosed when at least three abnormal parameters were present. If the median CMAP latency was greater than 4.2 ms or the median SNAP was greater than 3.6 ms, we used the 'mid-palm' technique to diagnose carpal tunnel syndrome (CTS). In this technique, the median nerve was stimulated at the wrist and the median SNAP was recorded in digit 3 at a 7-cm distance (palm). The median nerve was then stimulated at the palm at a 14-cm distance (wrist). Presence of CTS was considered when the ratio of palm to wrist latency was lower than 50%. All of the patients gave informed consent, and the study was approved by the ethics committee of our university. Patients were then divided into two groups according to the presence or absence of peripheral neuropathy. The clinical and laboratory findings were compared between the two groups.
Statistical analysis
Statistical analyses were performed with SPSS 13.0 for Windows (SPSS Inc., Chicago, IL, USA). For comparison between the two groups, a Mann-Whitney U test or t-test was used for continuous variables and a Fisher exact test was used for categorical variables. The variables were analyzed with univariate logistic regression analysis to determine their effects on polyneuropathic involvement. Odds ratios and 95% confidence intervals (CIs) were calculated for each factor. In addition, multivariable regression analyses were performed to assess the independent association between peripheral neuropathy and each factor. All of the variables with p-value <0.2 by univariate analysis were selected for the multivariable logistic regression analysis. A p-value of <0.05 was considered statistically significant.
RESULTS
A total of 30 RA patients (26 women and 4 men) were enrolled in this study. Of these, 10 patients showed peripheral neuropathy in the electrophysiological study: 2 had bilateral CTS, 5 had unilateral CTS, 1 had sensory polyneuropathy, and 2 had sensorimotor polyneuropathy. Two patients had peripheral neuropathy of the lower limbs, 1 patient had neuropathy of both upper and lower limbs, and 7 patients had isolated upper limb involvement. The mean ages of the patients with and without peripheral neuropathy were 69.4 and 56.5 years, respectively (p<0.05). The duration of the disease was 96.8 months in patients without peripheral neuropathy and 54.1 months in patients with peripheral neuropathy, respectively. All of the patients without peripheral neuropathy were in functional stage class I, whereas some of the patients with peripheral neuropathy were in class II and class IV. However, there was no statistically significant difference in the RA duration and functional stage between the two groups. Among the 20 patients without peripheral neuropathy, 13 patients (65.0%) showed a positive RF and 8 patients (40.0%) showed a positive anti-CCP antibody. In contrast, among the 10 patients with peripheral neuropathy, all of the patients were positive for RF, and 8 patients (80.0%) were positive for anti-CCP antibody. Patients with peripheral neuropathy were thus more likely to have a positive serological marker for RA than those without peripheral neuropathy; however, this difference was not statistically significant using the Fisher exact test (
Table 2).
We found that anti-CCP antibody was significantly associated with an increased risk of polyneuropathy using a univariate logistic regression model (relative risk [RR], 6.00; 95% CI, 1.00-35.91). Age was also significantly associated with presence of peripheral neuropathy in univariate logistic regression analysis (RR, 1.083; 95% CI, 1.00-1.17). Multiple regression analysis demonstrated that peripheral neuropathy in RA patients was independently increased by age (RR, 1.12; 95% CI, 1.02-1.13) and anti-CCP antibody (RR, 14.27; 95% CI, 1.37-148.26) (
Table 3). Age of patients did not show a difference according to the presence or absence of anti-CCP antibody. Age of patients who were positive for anti-CCP antibody and negative for anti-CCP antibody was 59.2±12.4 and 61.1±14.1 years, respectively. When we compared the odds ratio of anti-CCP antibody for peripheral neuropathy according to age, odds ratio of anti-CCP antibody was higher in the old age group (
Table 4). No significant association was found between peripheral neuropathy and gender, NSS, functional stage, ESR, CRP, type of medication, and RF.
DISCUSSION
The prevalence and electrophysiological findings of peripheral neuropathy and their relationship with demographic, clinical, and laboratory findings have not been clearly demonstrated in the literature. The prevalence of peripheral neuropathy and its related factors vary among previous studies, as shown in
Table 5 [
5,
6,
14,
15,
16]. Furthermore, it is difficult to compare studies examining peripheral neuropathy in RA because the inclusion criteria and neuropathy assessment methods varied between previous reports. In our current study, we reported a frequency of peripheral neuropathy, including entrapment neuropathy of 33.3% in RA patients, which appears to be lower than that in previous studies with a large series of patients, which included entrapment neuropathy as peripheral neuropathy. The frequency of peripheral neuropathy in this study was higher than the frequency of idiopathic polyneuropathy of 8%, which was reported previously in a population-based epidemiological study [
17].
Although we included RA patients with neurological symptoms in our current study, the prevalence of neuropathy in the electrophysiological study was lower than that in other studies. In addition, there was no relationship between the NSS and the presence of peripheral neuropathy, which may be because the NSS consists of questions that focus on positive symptoms, such as burning and tingling, which are subjectively reported by the patients. Furthermore neuropathic symptoms mimic the symptoms of arthritis. Because of these reasons, symptoms of patients might show a poor correlation with results of electrophysiological studies. A poor correlation between the clinical and electrophysiological parameters in our study is in accordance with the results of some studies [
6,
14], although not all of the studies [
18].
In our present study, we did not find a significant association between peripheral neuropathy and gender, RA duration, functional status of patients, RF, ESR, CRP, and type of medication. We found that RA patients with peripheral neuropathy were older than RA patients without peripheral neuropathy. Age is a known risk factor for polyneuropathy [
19], and RA patients with peripheral neuropathy in our electrophysiological study showed similar results. However, the prevalence of peripheral neuropathy in patients with RA in this study was higher than that of peripheral neuropathy in patients without the underlying disease.
The important finding of our current study was that patients who were positive for anti-CCP antibody showed an increased risk of peripheral neuropathy. The anti-CCP antibody has become a focus of attention for diagnosis and it is a marker of severe RA [
20]. A recent study reported that anti-CCP antibody is associated with human leukocyte antigen (HLA) class II RA-related susceptibility alleles and severe disease manifestations [
21]. Although some authors have observed a tendency for a positive association between anti-CCP antibody titer and extra-articular manifestations in RA, there is no data on the effects of anti-CCP antibody on the development of peripheral neuropathy [
22,
23,
24]. Our current study is the first study to investigate the relationship between anti-CCP antibody and the development of peripheral neuropathy in RA patients. According to our results, RA patients who had anti-CCP antibodies have about a 14-fold increased risk of peripheral neuropathy. Also, the effect of anti-CCP antibody on peripheral neuropathy seems to increase with age.
Our study was limited by its small sample size and cross-sectional design. In addition, we were unable to conduct an electrophysiological study for the same duration from symptom onset. Moreover, we were unable to determine a definite cause of peripheral neuropathy and CTS in this study; whether it was as a result of a direct nerve injury due to joint deformity or it was an independent disease. Further longitudinal studies in a large population are needed.
It is difficult to distinguish the symptoms of peripheral neuropathy from those of arthritis, and the subjective symptoms of patients do not correlate with electrophysiological results. Hence, electrophysiological studies should be performed in patients with RA, particular in older patients and anti-CCP antibody positive patients.
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported.
REFERENCES
- 1. Sakini RA, Abdul-Zehra IK, Al-Nimer MS. Neuropathic manifestations in rheumatoid arthritis: a clinical and electrophysiological assessment in a small sample of Iraqi patients. Ann Saudi Med 2005;25:247-249.
- 2. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62-67.
- 3. Johnson RL, Smyth CJ, Holt GW, Lubchenco A, Valentine E. Steroid therapy and vascular lesions in rheumatoid arthritis. Arthritis Rheum 1959;2:224-229.
- 4. Good AE, Christopher RP, Koepke GH, Bender LF, Tarter ME. Peripheral neuropathy associated with rheumatoid arthritis: a clinical and electrodiagnostic study of 70 consecutive rheumatoid arthritis patients. Ann Intern Med 1965;63:87-99.
- 5. Nadkar MY, Agarwal R, Samant RS, Chhugani SJ, Idgunji SS, Iyer S, et al. Neuropathy in rheumatoid arthritis. J Assoc Physicians India 2001;49:217-220.
- 6. Agarwal V, Singh R, Wiclaf , Chauhan S, Tahlan A, Ahuja CK, et al. A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol 2008;27:841-844.
- 7. Golding DN. Rheumatoid neuropathy. Br Med J 1971;2:169.
- 8. Pouget J. Vascular neuropathies. Rev Prat 2000;50:749-752.
- 9. Salih AM, Nixon NB, Gagan RM, Heath P, Hawkins CP, Dawes PT, et al. Anti-ganglioside antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. Br J Rheumatol 1996;35:725-731.
- 10. El M, Ashour S, Moustafa H, Ahmed I. Altered levels of soluble adhesion molecules in patients with rheumatoid arthritis complicated by peripheral neuropathy. J Rheumatol 2002;29:57-61.
- 11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
- 12. Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590-596.
- 13. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-2581.
- 14. Lanzillo B, Pappone N, Crisci C, di Girolamo C, Massini R, Caruso G. Subclinical peripheral nerve involvement in patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1196-1202.
- 15. Fleming A, Dodman S, Crown JM, Corbett M. Extra-articular features in early rheumatoid disease. Br Med J 1976;1:1241-1243.
- 16. Bayrak AO, Durmus D, Durmaz Y, Demir I, Canturk F, Onar MK. Electrophysiological assessment of polyneuropathic involvement in rheumatoid arthritis: relationships among demographic, clinical and laboratory findings. Neurol Res 2010;32:711-714.
- 17. Beghi E, Monticelli ML. Italian General Practitioner Study Group (IGPST). Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation of risk factors for polyneuropathy in two Italian communities. J Clin Epidemiol 1998;51:697-702.
- 18. Weller RO, Bruckner FE, Chamberlain MA. Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry 1970;33:592-604.
- 19. Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract 2004;17:309-318.
- 20. Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van't Hof M, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000;43:1831-1835.
- 21. van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004;50:2113-2121.
- 22. Ceccato F, Roverano S, Barrionuevo A, Rillo O, Paira S. The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Clin Rheumatol 2006;25:854-857.
- 23. Turesson C, Jacobsson LT, Sturfelt G, Matteson EL, Mathsson L, Ronnelid J. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 2007;66:59-64.
- 24. Kim SK, Park SH, Shin IH, Choe JY. Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. J Rheumatol 2008;35:995-1001.
Table 1Reference values for the nerve conduction study that were used in the present study
Table 2Characteristics of the patients in the two groups
Table 3Variables associated with peripheral neuropathy in RA
Table 4Effects of anti-CCP antibody on peripheral neuropathy according to age
Table 5Comparison between electrophysiological patterns of peripheral neuropathy and associated factors reported in the present and previous studies
Figure & Data
Citations
Citations to this article as recorded by
- Damage to the peripheral nervous system in rheumatoid arthritis: a review of current data, diagnostic criteria, and therapeutic strategies
Balkiya K. Mahmutova, Asem M. Orynbaeva, Aigerim N. Pernebaj, Marina A. Grigolashvili, Sharbany B. Battakova, Maral B. Otarbaeva
L.O. Badalyan Neurological Journal.2025; 6(1): 44. CrossRef - Clinical, neurophysiological, and radiological characteristics of peripheral neuropathy in patients with rheumatoid arthritis: A cross-sectional observational study
Mennatallah Sayed Abdelrazek, Basma Mohamed Ali Elnaggar, Ali Mahmoud Ahmed, Maha Salah Eldin Mohamed
Journal of the Neurological Sciences.2025; 473: 123523. CrossRef - The prevalence and clinical features of leflunomide‐associated peripheral neuropathy in patients with rheumatic disease in a New Zealand cohort
Gursimran Kaur, Murray Barclay, Joanne Mitchell, Sarah Jordan, Simon Stebbings
International Journal of Rheumatic Diseases.2024;[Epub] CrossRef - Quercetin and ibuprofen combination displayed anti-inflammatory effects and also extenuates the enteric neurons damage of arthritic rats
BRUNA THAIS DA SILVA, JULIANA VANESSA C. MARTINS-PERLES, GLEISON DAION P. BOSSOLANI, MARIANA M. LIMA, CAMILA C. SEHABER-SIERAKOWSKI, LUCAS B. GREMASCHI, JOÃO PAULO SILVEIRA E CUNHA, CIOMAR A. BERSANI-AMADO, JACQUELINE N. ZANONI
Anais da Academia Brasileira de Ciências.2024;[Epub] CrossRef - Prevalence of Subclinical Peripheral Neuropathy in Patients With Autoimmune Connective Tissue Disorders: An Observational Cross-Sectional Study
Mariraj Indiran, Priyadharshini Venugopalan, Gowrishankar Arumugam
Cureus.2024;[Epub] CrossRef - Rheumatoid arthritis as an internal disease
Martina Skácelová, Pavel Horák
Vnitřní lékařství.2024; 70(6): 358. CrossRef - Unveiling the Role of Nerve Conduction Studies (NCS) in Detecting Subclinical Peripheral Neuropathy in Autoimmune Disorders: A Cross-Sectional Study
Subbiah Senthilnathan, Gunasekaran Nallusamy, Priyadarshini Varadaraj, Keesari Sai Sandeep Reddy, Lokesh Kumar
Cureus.2024;[Epub] CrossRef - Polyneuropathy in Rheumatoid Arthritis (literature review)
Iuliia Zhelnina, Tatiana Baidina, Alexander Zhelnin, Tatiana Trushnikova, Elena Shishkina
Journal of Digital Art & Humanities.2024; 5(2): 47. CrossRef - Rheumatoid Neuropathy: A Brief Overview
Bhavya Rajeshwari, Sunil Kumar
Cureus.2023;[Epub] CrossRef - Corneal nerve loss and increased Langerhans cells are associated with disease severity in patients with rheumatoid arthritis
Gulfidan Bitirgen, Adem Kucuk, Mustafa Cagri Ergun, Gunhal Satirtav, Rayaz A. Malik
Eye.2023; 37(14): 2950. CrossRef - Prevalence of various forms of peripheral neuropathy in patients with systemic connective tissue diseases: A clinical and electrophysiological study
Vanja Djuric, Bojana Stamenkovic, Ivan Petkovic, Luka Djuric
Vojnosanitetski pregled.2023; 80(7): 561. CrossRef - A Neurological Complication in Rheumatoid Arthritis – A Scenario of Catastrophic Proportions
Megha Varshney, Sucharita Ray, Manod Reddy, Debajyoti Chatterjee, Kamalesh Chakravarty, Vikas Bhatia, Vivek Lal
Annals of Indian Academy of Neurology.2023; 26(4): 560. CrossRef - Pain-like behavior in the collagen antibody-induced arthritis model is regulated by lysophosphatidic acid and activation of satellite glia cells
Jie Su, Emerson Krock, Swapnali Barde, Ada Delaney, Johnny Ribeiro, Jungo Kato, Nilesh Agalave, Gustaf Wigerblad, Rosalia Matteo, Roger Sabbadini, Anna Josephson, Jerold Chun, Kim Kultima, Olivier Peyruchaud, Tomas Hökfelt, Camilla I. Svensson
Brain, Behavior, and Immunity.2022; 101: 214. CrossRef - Evaluation of peripheral neuropathy in lower limbs of patients with rheumatoid arthritis and its relation to fall risk
Fabio de Araújo Pereira, Mariana de Almeida Lourenço, Marcos Renato de Assis
Advances in Rheumatology.2022;[Epub] CrossRef - Postoperative Common Peroneal Nerve Injury of Seven Patients Within 2 Months: Case Reports and Analysis
Chengyi Cai, Yongxing Li, Wuhua Ma
Indian Journal of Surgery.2021; 83(5): 1283. CrossRef - Large fiber peripheral neuropathy in systemic sclerosis: A prospective study using clinical and electrophysiological definition
Jasmin Raja, Tharshannia Balaikerisnan, Letchumy Praba Ramanaidu, Khean Jin Goh
International Journal of Rheumatic Diseases.2021; 24(3): 347. CrossRef - Peripheral nervous system manifestations of rheumatological diseases
Kelly G. Gwathmey, Kelsey Satkowiak
Journal of the Neurological Sciences.2021; 424: 117421. CrossRef - Comparison of median nerve stiffness with and without rheumatoid arthritis by ultrasound real-time tissue elastography: A propensity score matching study
Shohei Anno, Tadashi Okano, Kenji Mamoto, Yuko Sugioka, Setsuko Takeda, Ayumi Hashimoto, Emi Yamashita, Rika Morinaka, Hatsue Ueda, Kentaro Inui, Tatsuya Koike, Hiroaki Nakamura
Modern Rheumatology.2020; 30(3): 481. CrossRef - Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis
Ji-Won Kim, Chang-Hee Suh
Journal of Clinical Medicine.2020; 9(6): 2008. CrossRef - Role of miR-9-5p in preventing peripheral neuropathy in patients with rheumatoid arthritis by targeting REST/miR-132 pathway
Zunzhong Li, Yanshan Li, Qinghua Li, Zhenchun Zhang, Li Jiang, Xingfu Li
In Vitro Cellular & Developmental Biology - Animal.2019; 55(1): 52. CrossRef - A classification framework for exploiting sparse multi-variate temporal features with application to adverse drug event detection in medical records
Francesco Bagattini, Isak Karlsson, Jonathan Rebane, Panagiotis Papapetrou
BMC Medical Informatics and Decision Making.2019;[Epub] CrossRef - Clinical characteristics of rheumatoid arthritis patients with peripheral neuropathy and potential related risk factors
Yanshan Li, Li Jiang, Zhenchun Zhang, Hong Li, Liangjun Jiang, Lili Wang, Zunzhong Li
Clinical Rheumatology.2019; 38(8): 2099. CrossRef - Periphere Nervenbeteiligung bei rheumatischen Erkrankungen
V. Casteleyn, K. Hahn, W. Stenzel, E. Siegert
Zeitschrift für Rheumatologie.2019; 78(4): 339. CrossRef - Chronic pain and central sensitization in immuno-inflammatory rheumatic diseases: pathogenesis, clinical manifestations, the possibility of using targeted disease modifying antirheumatic drugs
A. E. Karateev, E. L. Nasonov
Rheumatology Science and Practice.2019; 57(2): 197. CrossRef - Rheumatoid arthritis induces enteric neurodegeneration and jejunal inflammation, and quercetin promotes neuroprotective and anti-inflammatory actions
Gleison Daion Piovezana Bossolani, Bruna Thais Silva, Juliana Vanessa Colombo Martins Perles, Mariana Machado Lima, Flávia Cristina Vieira Frez, Sara Raquel Garcia de Souza, Camila Caviquioli Sehaber-Sierakowski, Ciomar Aparecida Bersani-Amado, Jacqueline
Life Sciences.2019; 238: 116956. CrossRef - Magnetic Resonance Imaging of the Digital Nerves of the Hand: Anatomy and Spectrum of Pathology
Charles H. Mitchell, Laura M. Fayad, Shivani Ahlawat
Current Problems in Diagnostic Radiology.2018; 47(1): 42. CrossRef - Pain pathogenesis in rheumatoid arthritis—what have we learned from animal models?
Emerson Krock, Alexandra Jurczak, Camilla I. Svensson
Pain.2018; 159(1): S98. CrossRef - A survey of people with foot problems related to rheumatoid arthritis and their educational needs
Andrea S. Graham, John Stephenson, Anita E. Williams
Journal of Foot and Ankle Research.2017;[Epub] CrossRef - Has the median nerve involvement in rheumatoid arthritis been overemphasized?
Rajalingham Sakthiswary, Rajesh Singh
Revista Brasileira de Reumatologia (English Edition).2017; 57(2): 122. CrossRef - O envolvimento do nervo mediano na artrite reumatoide tem sido excessivamente valorizado?
Rajalingham Sakthiswary, Rajesh Singh
Revista Brasileira de Reumatologia.2017; 57(2): 122. CrossRef - Foot Health Education for People with Rheumatoid Arthritis: '…. A Game of Chance…' – A Survey of Patients' Experiences
Andrea S. Graham, Anita E. Williams
Musculoskeletal Care.2016; 14(1): 37. CrossRef - Foot neuropathy in rheumatoid arthritis patients: clinical, electrophysiological, and ultrasound studies
Abd El-Samad I. El-Hewala, Samar G. Soliman, Alaa A. Labeeb, Ashraf A. Zytoon, Amira Tarek El-Shanawany
Egyptian Rheumatology and Rehabilitation.2016; 43(3): 85. CrossRef - Polyneuropathy and radiculopathy in rheumatoid arthritis patients with low back pain: Clinical characteristics, functional disability, depression, anxiety and quality of life
Ebru Karaca Umay, Ajda Bal, Ibrahim Gundogdu, Pinar Bora Karsli
The Egyptian Rheumatologist.2015; 37(4): 151. CrossRef - Neuropsychiatric manifestations in rheumatoid arthritis
Andrei F. Joaquim, Simone Appenzeller
Autoimmunity Reviews.2015; 14(12): 1116. CrossRef
